Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=54121#.VO2HsSzQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=54121#.VO2HsSzQrzE
Affiliation(s)
1Department of Pediatric Ophthalmology and Strabismus, Dr Shroff’s Charity Eye Hospital, New Delhi, India.
2Department of Ophthalmology, Dayanand Medical College and Hospital, Ludhiana, India.
3Department of Ophthalmology, BPS Government Medical College for Women, Sonepat, India.
4Department of Ophthalmology, NNJS Banke Fateh Bal Eye Hospital, Nepalganj, Nepal.
2Department of Ophthalmology, Dayanand Medical College and Hospital, Ludhiana, India.
3Department of Ophthalmology, BPS Government Medical College for Women, Sonepat, India.
4Department of Ophthalmology, NNJS Banke Fateh Bal Eye Hospital, Nepalganj, Nepal.
ABSTRACT
Purpose:
Use of appropriate cycloplegic agent is an essential area of management
in children with strabismus and refractive error. This study was
designed to audit our own department’s understanding and practice with
respect to cycloplegia. Methods: Children in age group of 0 - 12 years
with refractive errors and strabismus were evaluated with respect to
four parameters: adherence to cycloplegic refraction (group-I), choice
of cycloplegic agent (group-II), dosage of cycloplegia (group-III) and
duration of cycloplegia (group-IV). Following the initial audit, the
hospital audit committee evaluated the results; thereafter concerned
staff was educated and aidememoires of the dilatation protocol were
introduced; a second audit cycle was carried out after 3 months.
Results: First and second audit cycle included 334 children (mean age
6.2 ± 2.2 years) and 436 children (mean age 7.25 ± 2.9 years)
respectively. A statistically significant improvement was found in all
four parameters in the second audit cycle: adherence to dilation
protocol (82.3% in first cycle to 94.3% in second cycle; p = 0.001),
choice of cycloplegic agent (77% in the first cycle to 94.8% in the
second cycle; p = 0.001), dosage of cycloplegic agent (84% in the first
cycle to 96.3% in the second cycle; p = 0.001) and duration of
cycloplegic agents (65% in the first cycle to 97.5% in the second cycle;
p = 0.001 for CTC and 71.8% in the first cycle to 98% in the second
cycle; p = 0.001 for Tropicamide). Conclusions: A complete audit cycle
demonstrated a statistically significant improvement in all four
parameters related to cycloplegic refraction in children. Regular
auditing coupled with targeted interventions aimed to maintain the “best
practice guidelines” for determination of refractive errors in children
could prove effective in improving standards of clinical practice.
Cite this paper
References
Ganesh, S. , Arora, P. , Sethi, S. and Gurung, C. (2015) Cycloplegic Refraction in Children: A Complete Audit Cycle. Open Journal of Ophthalmology, 5, 41-45. doi: 10.4236/ojoph.2015.51007.
[1] | Shah, P., Jacks, A.S. and Adams, G.G. (1997) Paediatric Cycloplegia: A New Approach. Eye, 11, 845-846. http://dx.doi.org/10.1038/eye.1997.216 |
[2] | Mehta, A. (1999) Chief Complaint, History and Physical Examination. In: Santiago, A.P. and Rosenbaum, A.I., Eds., Clinical Strabismus Management, Saunders, Philadelphia, 18. |
[3] | Miranda,
M.N. (1972) Residual Accommodation. A Comparison between Cyclopentolate
1 Percent and a Combination of Cyclopentolate 1 Percent and Tropicamide
1 Percent. Archives of Ophthalmology, 87, 515-517. http://dx.doi.org/10.1001/archopht.1972.01000020517004 |
[4] | Manny, R.E., Hussein, M., Scheiman, M., et al. (2001) Tropicamide (1%): An Effective Cycloplegic Agent for Myopic children. Investigative Ophthalmology & Visual Science, 42, 1728-1735. |
[5] | Rosenbaum,
A.L., Bateman, J.B., Bremer, D.L., et al. (1981) Cycloplegic Refraction
in Esotropic Children. Cyclopentolate versus Atropine. Ophthalmology,
88, 1031-1034. http://dx.doi.org/10.1016/S0161-6420(81)80032-2 |
[6] | (1992) Guidelines for Clinical Practice: From Development to Use. In: Lohr, K.N., Field, M.J., Eds., Institute of Medicine Committee on Clinical Practice Guidelines, National Academy Press, Washington DC,. |
[7] | Cabana,
M.D., Rand, C.S., Powe, N.R., et al. (1999) Why Don’t Physicians Follow
Clinical Practice Guidelines? A Framework for Improvement. JAMA, 282,
1458-1465. http://dx.doi.org/10.1001/jama.282.15.1458 |
[8] | Foy,
R., MacLennan, G., Grimshaw, J., et al. (2002) Attributes of Clinical
Recommendations That Influence Change in Practice Following Audit and
Feedback. Journal of Clinical Epidemiology, 55, 717-722. http://dx.doi.org/10.1016/S0895-4356(02)00403-1 |
[9] | Grol,
R. and Grimshaw, J. (2003) From Best Evidence to Best Practice:
Effective Implementation of Change in Patients’ Care. The Lancet, 362,
1225-30. http://dx.doi.org/10.1016/S0140-6736(03)14546-1 |
[10] | Grol, R. and Buchan, H. (2006) Clinical Guidelines: What Can We Do to Increase Their Use? Medical Journal of Australia, 185, 301-302. |
[11] | Freemantle, N. (2000) Implementation Strategies. Family Practice, 17, S7-S10. http://dx.doi.org/10.1093/fampra/17.suppl_1.S7 eww150225lx |
评论
发表评论